20
Oct

While the testosterone therapy field is under fire from government regulators, Menlo Park, CA-based TesoRx is licensing its oral-testosterone replacement therapy to a subsidiary of South African generics maker Aspen Pharmacare.

…read more

Source: TesoRx licenses oral low-T drug to Aspen amid FDA crackdown

    

0 No comments